Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIO) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001533040 · PHIO · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001533040 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has submitted 869 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001533040, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Phio Pharmaceuticals Corp.'s most comprehensive regulatory disclosure. The most recent Phio Pharmaceuticals Corp. 10-K was filed on 2026-03-05 for fiscal year ending 2026. Historical PHIO 10-K annual reports are available from 2011 through 2026.
Investors researching Phio Pharmaceuticals Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
PHIO SEC Filings · 8 questionsPhio Pharmaceuticals Corp. (PHIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 869 filings and access original documents at no cost. Phio Pharmaceuticals Corp.'s CIK is 0001533040.